These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3093566)

  • 41. Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3.
    Geppert TD; Lipsky PE
    J Immunol; 1987 Mar; 138(6):1660-6. PubMed ID: 3102594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation requirements for normal T cells: accessory cell-dependent and -independent stimulation by anti-receptor antibodies.
    Bekoff M; Kubo R; Grey HM
    J Immunol; 1986 Sep; 137(5):1411-9. PubMed ID: 3489033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells.
    Wassmer P; Chan C; Lögdberg L; Shevach EM
    J Immunol; 1985 Oct; 135(4):2237-42. PubMed ID: 3897371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
    Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells.
    Dieli F; Asherson GL; Romano GC; Sireci G; Gervasi F; Salerno A
    J Immunol; 1994 Mar; 152(6):2698-704. PubMed ID: 8144876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of the local graft-vs.-host reaction in rats by treatment with a monoclonal antibody specific for the interleukin 2 receptor.
    Volk HD; Brocke S; Osawa H; Diamantstein T
    Eur J Immunol; 1986 Oct; 16(10):1309-12. PubMed ID: 2945730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo effects of GK1.5 (anti-L3T4a) monoclonal antibody on induction and expression of delayed-type hypersensitivity.
    Miller SD; Jenkins MK
    Cell Immunol; 1985 May; 92(2):414-26. PubMed ID: 2859929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin.
    Diamantstein T; Volk HD; Tilney NL; Kupiec-Weglinski J
    Immunobiology; 1986 Sep; 172(3-5):391-9. PubMed ID: 3100433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.
    Kelley VE; Bacha P; Pankewycz O; Nichols JC; Murphy JR; Strom TB
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3980-4. PubMed ID: 3131768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Self-reactive delayed type hypersensitivity induced in mice by syngeneic lymphoblasts. II. Isolation of two distinct lymphoblast antigens, one of which reacts (or cross-reacts) with anti-H-2Dd monoclonal antibody.
    Klein I; Klein BY; Naor D
    Scand J Immunol; 1988 Feb; 27(2):209-22. PubMed ID: 3422511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization.
    Puccetti P; Bianchi R; Romani L; Cenci E; Fioretti MC
    Int J Cancer; 1989 Feb; 43(2):279-84. PubMed ID: 2465277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-reactive delayed type hypersensitivity induced in mice by syngeneic lymphoblasts. III. Immunological characterization of the small and large antigens of the blast cells.
    Klein I; Naor D
    Scand J Immunol; 1988 Apr; 27(4):385-92. PubMed ID: 2966434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivo.
    Bogers WM; Lang F; Parker KE; Le Mauff B; Anegon I; Jacques Y; Soulillou JP
    Transplantation; 1994 Oct; 58(8):932-9. PubMed ID: 7940738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serotonin initiation of delayed-type hypersensitivity: mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody.
    Askenase PW; Herzog WR; Millet I; Paliwal V; Ramabhadran R; Rochester C; Geba GP; Ptak W
    Skin Pharmacol; 1991; 4 Suppl 1():25-42. PubMed ID: 1684905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delayed-type hypersensitivity.
    Luo Y; Dorf ME
    Curr Protoc Immunol; 2001 May; Chapter 4():Unit 4.5. PubMed ID: 18432796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibodies directed at mouse IL-2-R alpha and beta chains act in synergy to abolish T-cell proliferation in vitro and delayed type hypersensitivity reaction in vivo.
    François C; Dantal J; Sorel M; Cherel M; Miyasaka M; Soulillou JP; Jacques Y
    Transpl Int; 1996; 9(1):46-50. PubMed ID: 8748410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of expression of delayed hypersensitivity by neutralizing monoclonal anti-T-cell fibronectin antibody.
    Mandy S; Feng Z; Canfield LS; Mandy K; Quan X; Rowehl RA; Khan MY; Akiyama SK; Godfrey HP
    Immunology; 1994 Dec; 83(4):582-8. PubMed ID: 7875739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Further study of the problem of specific cellular receptors in delayed hypersensitivity].
    Artemova AG
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):80-5. PubMed ID: 315679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Syngeneic red blood cell-induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice.
    Nazimek K; Bustos-Morán E; Blas-Rus N; Nowak B; Ptak W; Askenase PW; Sánchez-Madrid F; Bryniarski K
    Clin Exp Allergy; 2019 Nov; 49(11):1487-1499. PubMed ID: 31365154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.